EP0700430B1 — Methods for selectively stimulating proliferation of t cells
Assigned to THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Expires 2005-04-20 · 21y expired
What this patent protects
Methods for inducing a population of T cells to proliferate are described which involve activating the T cells with a first agent which provides a primary activation signal to the T cells; and stimulating the activated T cells with a second agent which stimulates an accessory mol…
USPTO Abstract
Methods for inducing a population of T cells to proliferate are described which involve activating the T cells with a first agent which provides a primary activation signal to the T cells; and stimulating the activated T cells with a second agent which stimulates an accessory molecule on the surface of the T cells.
Drugs covered by this patent
- Copiktra (DUVELISIB) · Secura
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.